class="post-template-default single single-post postid-23918 single-format-standard wp-custom-logo wp-embed-responsive link-highlight-style2 default-layout rishi-has-blocks rightsidebar rt-loading"itemscope="" itemtype="" data-link="type-2" data-forms="classic" data-prefix="single_blog_post" data-header="type-1:sticky" data-footer="type-1" itemscope="itemscope" itemtype="" >

NASDAQ Wellness firm centered on Hair Loss, Eczema and Burn Treatment appoints New Market Distributor: NASDAQ: JUPW


jupw products brands

JUPW Products Brands

jupw product line

$JUPW Product Line

jupw safe sea

JUPW Safe Sea

jupw canisun

JUPW Canisun

$JUPW Appoints Ardis with over 20 years of expertise within the business and is a trusted companion for over 500 seashore and surf outlets in Florida.

Jupiter Wellness, Inc (NASDAQ:(NASDAQ: JUPW))

I’m more than happy with our progress in decreasing our working bills whereas growing our revenues. We anticipate continued income progress and lowered bills because the demand for our merchandise”

— Brian John, CEO of JUPW

JUPITER, FL, UNITED STATES, December 5, 2022 / — • Digital Dividends will proceed a Short Squeeze of Great Upward Pressure.

• Active Research Programs Developing Multiple Health & Wellness Product


• Growing Revenues from Consumer Products, Contract Research, and Licensing.

• Eris Oaknet Healthcare & Cosmofix Technovation Launch Marketing of JUPW Products for the India Marketplace.

• Recently Regained Compliance with NASDAQ Minimum Bid Price Requirement.

• New BOD Member Appointed who Reported Insider Purchase of 122,000 Shares.

• Exclusive Licensing Agreement with Rejoy, Inc. to Develop Products for Various Treatments in Women with Cancer.

• Notice of Allowance for Patent Titled “Minoxidil Adjuvant Therapies.”

• Clinical Trial Comparison of JW-100 and EUCRISA for the Treatment of Eczema.

• JUPW Shares Currently Considered Over-Sold & Over-Shorted by Watch Groups.

Jupiter Wellness, Inc. (NASDAQ: JUPW)$JUPW is a wellness firm centered on hair loss, eczema, burns, and all-around wellness, introduced at this time the appointment of Ardis Enterprises, LLC (“Ardis”) as its unique distributor for promoting NoStingz and CaniSun sunscreen merchandise within the Florida market.

Established in 2020, Ardis is a number one distributor of solar care merchandise, skateboards, and seashore store novelties within the State of Florida. Founded by Ben Ardis, with greater than 20 years of expertise within the business, Ardis has change into a trusted companion for over 500 seashore and surf outlets in Florida.

The settlement with Ardis will allow Jupiter Wellness to broaden its presence within the Florida market and meet the rising demand for high-quality sunscreen merchandise. Jupiter Wellness’s vary of sunscreen merchandise are formulated with pure components and backed by rigorous scientific testing. The Company’s NoStingz model features a line of patent-pending jellyfish sting prevention sunscreen that protects customers from jellyfish and sea lice.


Jupiter Wellness, Inc. (NASDAQ: JUPW) is a diversified firm that helps well being and wellness by researching and growing over-the-counter (OTC) merchandise and mental property. The JUPW product pipeline addresses a spread of situations, together with hair loss, eczema, burns, and sexual wellness. Revenue is generated via the gross sales of OTC and shopper merchandise, contract analysis agreements, and licensing royalties.

Buyins.internet, a service that tracks investor shorting in public firms, experiences that JUPW has been experiencing substantial short-selling exercise over the previous a number of weeks. Data from mid-September via early November point out that over 216 million shares had been bought brief throughout this time interval, putting unusually sturdy downward strain on the JUPW pps. These short-sold shares have to be coated in some unspecified time in the future and Buyins.internet is projecting a possible brief squeeze for JUPW might happen within the close to future.

StockWireNews has additionally been monitoring JUPW in current weeks and is at the moment alerting its followers to the potential for JUPW to leap in share value on account of a number of constructive catalysts from the corporate in addition to the present over-sold and probably over-shorted situation of JUPW shares within the markets.

• JUPW Regains Compliance with NASDAQ Minimum Bid Price Requirement

On November 18th JUPW introduced that it had acquired a written letter from Nasdaq, which has decided that the Company has met the minimal bid requirement from November 4th to November 17, 2022. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and this matter is now closed.

• Eris Oaknet Healthcare and Cosmofix Technovation Announce the Market Launch of JUPW Photocil Products for the Indian Market

On November seventeenth JUPW introduced that Eris Oaknet Healthcare Pvt Ltd and Cosmofix Technovation Pvt Ltd had market launch conferences for JUPWPhotocil merchandise for the Indian market. The Eris Oaknet product is branded as “Photofirst” in India.

The JUPW scientific group introduced at conferences in Mumbai hosted by executives from Eris Oaknet and Cosmofix to coincide with the product launch.

The International Speaker Program in Mumbai, sponsored by Eris Oaknet, hosted over 100 dermatologists with audio system that included Professor Andy Goren, inventor of the know-how, Professor Torello Lotti, University of Rome, a world-renowned skilled within the remedy of vitiligo, and Dr. Glynn Wilson, Chief Scientific Officer of JUPW, who introduced the Company’s pipeline of merchandise. Local dermatology specialists included Dr. Pravin Banodkar, Skin Crest Clinic, Mumbai, and Dr. Asheem Sharma, Chief Dermatologist, Skin Saga Center for Dermatology, West Mumbai.

JUPW introduced that Photofirst had been accredited by the Central Drugs Standard Control Organisation (CDSCO), the “FDA of India”, on the market in India. Earlier this yr, Sanpellegrino Cosmetics Pvt Ltd & Cosmofix Technovation Pvt Ltd signed a licensing settlement with JUPW for the distribution and gross sales of the Photocil product in 31 international locations, together with India.

• Third Quarter Revenues in 2022 Jump to $1,569,925 Compared to Revenues of $687,928 in Third Quarter of 2021

On November 14th JUPW introduced its monetary outcomes for the Third Quarter ended September 30, 2022. JUPW generated $1,569,925 in revenues for the three months that ended September 30, 2022, in comparison with $687,928 for a similar interval in 2021. In addition to the revenues booked within the Third Quarter, JUPW’s wholly-owned subsidiary, SRM Entertainment, acquired $3.6 million in assured buy orders from the world’s largest amusement parks. These revenues will probably be realized as soon as the orders are shipped from our services.

Brian John, CEO of JUPW, stated, “I am very pleased with our progress in reducing our operating expenses while increasing our revenues. We anticipate continued revenue growth and reduced expenses as the demand for our products and services grows steadily. With combined sales orders shipped or received in the Third Quarter of over $5 million just coming off a record revenue in the Second Quarter, we are well on our way toward profitability by mid-2023.” John continued, “We plan to file to spin off our SRM division to our shareholders as its own separate NASDAQ traded company by year-end. Jupiter Wellness will remain the largest shareholder while enabling us to access additional capital to grow the SRM business at a faster pace.”

• Highlights in Third Quarter

Dr. Skender Fani, the Chairman of Otis Elevator-Austria, Heim GmbH, was appointed to the JUPW Board of Directors. On November 1, Dr. Fani filed a Form 4 reporting the acquisition of 122,000 shares.

JUPW signed an unique licensing settlement with Rejoy, Inc., a California Corporation, to develop prescription merchandise for the remedy of nipple neuropathies and related sexual issues in girls which were handled for breast most cancers.

The United States Patent and Trademark Office granted a discover of allowance for patent utility No. 16/747,685, titled “Minoxidil Adjuvant Therapies.”

• JUPW Re-Opens Enrollment in Clinical Trial Comparison of JW-100 and EUCRISA for the Treatment of Eczema

Expected to Complete Patient Enrollment of Clinical Trial in December 2022

On November tenth JUPW introduced that it has re-opened enrollment in a scientific trial aimed toward evaluating the prevalence of JW-100, a novel cannabidiol topical cream, in a head-to-head examine in opposition to EUCRISA, an FDA Approved topical remedy for eczema developed by Pfizer.

The examine was placed on maintain to unravel stability points within the authentic JW-100 formulation. These points had been addressed and resolved to the satisfaction of the examine’s scientific investigators.

JUPW CEO Brian John stated “Due to the nature of a double-blind study, we are only able to access certain data from the first run of this trial. However, what we have seen suggests to our team of scientists that we are on the right track and that this study warrants continuation. We are very encouraged by this update and hope to prove that our JW-100 is as effective, if not superior to a leading drug already on the market that does hundreds of millions in revenue. We hope to have the second half of this trail completed in the first quarter of 2023.”

• Plan to Spin Off Caring Brands, Inc. as Digital Securities Dividend to JUPW Shareholders

On November seventh JUPW introduced that it has plans to switch and spin off forty p.c (40%) of the Company’s wholly-owned subsidiary, Caring Brands, Inc., by means of a dividend within the type of digital securities to JUPW shareholders with a document date to happen in late November. JUPW will keep sixty p.c (60%). The spin-off transaction will probably be topic to numerous situations, together with Caring Brands, Inc. assembly the {qualifications} for future itemizing on the Blockchain-powered Securities Exchange Upstream, the revolutionary buying and selling app for digital securities and NFTs powered by Horizon Fintex (“Horizon”) and MERJ Exchange Limited (“MERJ”). Management’s intention is to publicly listing Caring Brands, Inc. by way of a list on Upstream in December 2022.

Caring Brands, Inc. is an progressive developer of cannabidiol (CBD) primarily based therapeutics and wellness merchandise. The Company’s stock of CBD-enhanced skin-care therapeutics addresses a spread of indications together with skincare and basic wellness. The Company generates income via the manufacturing, distribution, and advertising of a various line of shopper merchandise infused with CBD.

The deliberate twin itemizing on Upstream is designed to supply Caring Brands, Inc. the chance to entry a world, digital-first investor base that may commerce utilizing USDC digital foreign money together with bank cards, debit playing cards, PayPal, and USD, unlocking liquidity and enhancing value discovery whereas globalizing the chance to spend money on Caring Brands, Inc. Once accredited for itemizing on Upstream, JUPW shareholders of document will be capable of set up the Upstream App and obtain the dividend shares. Details on how shareholders of document will obtain their dividend shares and easy methods to commerce them on Upstream will probably be defined upon notification of the dividend’s document date.

DISCLAIMER: This article is solely for informational functions and isn’t a advice in any approach for getting or promoting shares

Brian John, CEO
Jupiter Wellness, Inc
+1 561-244-7100
email us here
Visit us on social media:

Jupiter Wellness NASDAQ: JUPW


s.parentNode.insertBefore(t,s)(window, document,’script’,
fbq(‘init’, ‘251889322717210’);
fbq(‘track’, ‘PageView’);

Source by [author_name]

Leave a Reply

Your email address will not be published. Required fields are marked *